Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 1 Depression 1

Interventions

Therapeutics 28 Psychiatric Rehabilitation 21 Surveys and Questionnaires 14 Cognitive Behavioral Therapy 12 Psilocybin 8 Methods 8 Ketamine 8 Early Intervention, Educational 8 Saline Solution 7 Yoga 6 Mindfulness-Based Cognitive Therapy 6 Interviews as Topic 6 Esketamine 6 Psychosocial Intervention 5 Mindfulness 5 Escitalopram 5 Behavior Therapy 5 Methylphenidate 4 Exercise Therapy 4 Exercise 4 Educational Status 4 Counseling 4 Control Groups 4 Acupuncture Therapy 4 Standard of Care 3 Psychotherapy 3 Palliative Care 3 Niacin 3 Mindfulness-Based Stress Reduction 3 Melatonin 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Depression × Milnacipran × Clear all

NCT02783430 2025-12-16

KETAPAL

University Hospital, Lille

Phase 2/3 Completed

Depression, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡